So, Futibatinib is this big deal because it stops something called the Fibroblast Growth Factor Receptor (FGFR) that’s a real problem in cholangiocarcinoma when there’s this FGFR2 thing going on. It works by blocking this FGFR signaling stuff. That’s like a big deal in how cholangiocarcinoma grows and gets worse.
You get it as 4 mg tablets, but you take 20 mg a day, just once. Each bottle has 28 of these tablets. They tailor Futibatinib treatment to people with tumors that have this FGFR2 fusion thing, which you find out through tests.
It’s just a pill, so it’s easy to take for patients.
Reviews
There are no reviews yet.